Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD 7.28
-0.03 (-0.41%)
Apr 17, 2026, 2:15 PM HKT
Mega Genomics Revenue
In the year 2025, Mega Genomics had annual revenue of 247.15M CNY with 50.49% growth. Mega Genomics had revenue of 165.87M in the half year ending December 31, 2025, with 67.75% growth.
Revenue
247.15M CNY
Revenue Growth
+50.49%
P/S Ratio
5.94
Revenue / Employee
1.22M CNY
Employees
203
Market Cap
1.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 247.15M | 82.92M | 50.49% |
| Dec 31, 2024 | 164.23M | 12.93M | 8.54% |
| Dec 31, 2023 | 151.30M | 5.57M | 3.82% |
| Dec 31, 2022 | 145.73M | -91.46M | -38.56% |
| Dec 31, 2021 | 237.19M | 33.97M | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 6.61B |
| Adicon Holdings | 2.94B |
| Kindstar Globalgene Technology | 1.04B |
| Yunkang Group | 669.23M |
| Biosino Bio-Technology and Science Incorporation | 205.08M |
| Guanze Medical Information Industry (Holding) | 98.42M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 73.50M |